Literature DB >> 15767442

RNA polymerase I-driven minigenome system for Ebola viruses.

Allison Groseth1, Heinz Feldmann, Steven Theriault, Gülsah Mehmetoglu, Ramon Flick.   

Abstract

In general, Ebola viruses are well known for their ability to cause severe hemorrhagic fever in both human and nonhuman primates. However, despite substantial sequence homology to other members of the family Filoviridae, Reston ebolavirus displays reduced pathogenicity for nonhuman primates and has never been demonstrated to cause clinical disease in humans, despite its ability to cause infection. In order to develop a tool to explore potential roles for transcription and replication in the reduced pathogenicity of Reston ebolavirus, we developed an RNA polymerase I (Pol I)-driven minigenome system. Here we demonstrate successful Reston ebolavirus minigenome rescue, including encapsidation, transcription, and replication, as well as the packaging of minigenome transcripts into progeny particles. The Pol I-driven Reston ebolavirus minigenome system provides a higher signal intensity with less background (higher signal-to-noise ratio) than a comparable T7-driven Reston ebolavirus minigenome system which was developed simultaneously. Successful Reston ebolavirus minigenome rescue was also achieved by the use of helper plasmids derived from the closely related Zaire ebolavirus or the more distantly related Lake Victoria marburgvirus. The use of heterologous helper plasmids in the Reston ebolavirus minigenome system yielded levels of reporter expression which far exceeded the level produced by the homologous helper plasmids. This comparison between minigenomes and helper plasmids from different filovirus species and genera indicates that inherent differences in the transcription and/or replication capacities of the ribonucleoprotein complexes of pathogenic and apathogenic filoviruses may exist, as these observations were confirmed in a Lake Victoria marburgvirus minigenome system.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15767442      PMCID: PMC1061559          DOI: 10.1128/JVI.79.7.4425-4433.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  Reverse genetics for crimean-congo hemorrhagic fever virus.

Authors:  Ramon Flick; Kirsten Flick; Heinz Feldmann; Fredrik Elgh
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

2.  Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase.

Authors:  T R Fuerst; E G Niles; F W Studier; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

3.  RNA synthesis: strategies for the use of bacteriophage RNA polymerases.

Authors:  G Krupp
Journal:  Gene       Date:  1988-12-10       Impact factor: 3.688

4.  Human influenza a viral genes responsible for the restriction of its replication in duck intestine.

Authors:  Masato Hatta; Peter Halfmann; Krisna Wells; Yoshihiro Kawaoka
Journal:  Virology       Date:  2002-04-10       Impact factor: 3.616

5.  Rescue of Hantaan virus minigenomes.

Authors:  Kirsten Flick; Jay W Hooper; Connie S Schmaljohn; Ralf F Pettersson; Heinz Feldmann; Ramon Flick
Journal:  Virology       Date:  2003-02-15       Impact factor: 3.616

6.  Analysis of the role of predicted RNA secondary structures in Ebola virus replication.

Authors:  Sharon M Crary; Jonathan S Towner; Jessica E Honig; Trevor R Shoemaker; Stuart T Nichol
Journal:  Virology       Date:  2003-02-15       Impact factor: 3.616

Review 7.  Ebola virus: from discovery to vaccine.

Authors:  Heinz Feldmann; Steven Jones; Hans-Dieter Klenk; Hans-Joachim Schnittler
Journal:  Nat Rev Immunol       Date:  2003-08       Impact factor: 53.106

8.  Functional analysis of the noncoding regions of the Uukuniemi virus (Bunyaviridae) RNA segments.

Authors:  Kirsten Flick; Anna Katz; Anna Overby; Heinz Feldmann; Ralf F Pettersson; Ramon Flick
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

9.  Molecular characterization of an isolate from the 1989/90 epizootic of Ebola virus Reston among macaques imported into the United States.

Authors:  Allison Groseth; Ute Ströher; Steven Theriault; Heinz Feldmann
Journal:  Virus Res       Date:  2002-08       Impact factor: 3.303

10.  Recombinant lymphocytic choriomeningitis virus expressing vesicular stomatitis virus glycoprotein.

Authors:  Daniel D Pinschewer; Mar Perez; Ana B Sanchez; Juan Carlos de la Torre
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-13       Impact factor: 11.205

View more
  32 in total

1.  Minigenome-based reporter system suitable for high-throughput screening of compounds able to inhibit Ebolavirus replication and/or transcription.

Authors:  Luke D Jasenosky; Gabriele Neumann; Yoshihiro Kawaoka
Journal:  Antimicrob Agents Chemother       Date:  2010-04-26       Impact factor: 5.191

2.  Duck hepatitis A virus serotype 1 minigenome: a model for studying the viral 3'UTR effect on viral translation.

Authors:  Ruiying Liang; Chuanfeng Li; Hongyan Jin; Chunchun Meng; Zongyan Chen; Jie Zhu; Qiuhong Miao; Chan Ding; Guangqing Liu
Journal:  Virus Genes       Date:  2015-11-17       Impact factor: 2.332

3.  Ebola virus VP35-VP40 interaction is sufficient for packaging 3E-5E minigenome RNA into virus-like particles.

Authors:  Reed F Johnson; Sarah E McCarthy; Peter J Godlewski; Ronald N Harty
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

4.  Rescue of recombinant Marburg virus from cDNA is dependent on nucleocapsid protein VP30.

Authors:  Sven Enterlein; Viktor Volchkov; Michael Weik; Larissa Kolesnikova; Valentina Volchkova; Hans-Dieter Klenk; Elke Mühlberger
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

5.  Establishment and characterization of plasmid-driven minigenome rescue systems for Nipah virus: RNA polymerase I- and T7-catalyzed generation of functional paramyxoviral RNA.

Authors:  Alexander Freiberg; Lhia Krista Dolores; Sven Enterlein; Ramon Flick
Journal:  Virology       Date:  2007-09-27       Impact factor: 3.616

6.  The Ebola virus ribonucleoprotein complex: a novel VP30-L interaction identified.

Authors:  A Groseth; J E Charton; M Sauerborn; F Feldmann; S M Jones; T Hoenen; H Feldmann
Journal:  Virus Res       Date:  2008-12-16       Impact factor: 3.303

7.  Filovirus replication and transcription.

Authors:  Elke Mühlberger
Journal:  Future Virol       Date:  2007-03       Impact factor: 1.831

8.  Novel Arenavirus Entry Inhibitors Discovered by Using a Minigenome Rescue System for High-Throughput Drug Screening.

Authors:  Jessica Y Rathbun; Magali E Droniou; Robert Damoiseaux; Kevin G Haworth; Jill E Henley; Colin M Exline; Hyeryun Choe; Paula M Cannon
Journal:  J Virol       Date:  2015-06-03       Impact factor: 5.103

9.  The L-VP35 and L-L interaction domains reside in the amino terminus of the Ebola virus L protein and are potential targets for antivirals.

Authors:  Martina Trunschke; Dominik Conrad; Sven Enterlein; Judith Olejnik; Kristina Brauburger; Elke Mühlberger
Journal:  Virology       Date:  2013-04-11       Impact factor: 3.616

10.  Recovery of an arenavirus entirely from RNA polymerase I/II-driven cDNA.

Authors:  Lukas Flatz; Andreas Bergthaler; Juan Carlos de la Torre; Daniel D Pinschewer
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-13       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.